Split History
ETFs Holding AMRI »    AMRI Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Albany Molecular Research is a global contract research and manufacturing organization providing customers integrated drug discovery, development, and manufacturing services. Co. supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of active pharmaceutical ingredients and the manufacturing of drug product for new and generic drugs, as well as research, development and manufacturing for the agrochemical and other industries. In addition, Co. provides analytical and testing services to the medical device and personal care industry, with locations in the U.S., Europe, and Asia. According to our AMRI split history records, Albany Molecular Research has had 1 split.
AMRI split history picture
Albany Molecular Research (AMRI) has 1 split in our AMRI split history database. The split for AMRI took place on August 25, 2000. This was a 2 for 1 split, meaning for each share of AMRI owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Albany Molecular Research splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the AMRI split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Albany Molecular Research shares, starting with a $10,000 purchase of AMRI, presented on a split-history-adjusted basis factoring in the complete AMRI split history. AMRI split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/24/2007
End date: 07/21/2017
Start price/share: $16.37
End price/share: $21.70
Dividends collected/share: $0.00
Total return: 32.56%
Average Annual Total Return: 2.86%
Starting investment: $10,000.00
Ending investment: $13,257.61
Years: 10.00
Date Ratio
08/25/20002 for 1
AMRI is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AMRN Split History
AMSG Split History
ANCI Split History
ANIP Split History
ANTH Split History
APEN Split History
APHB Split History
APPY Split History
APRI Split History
ARA Split History

SUPERVALU INC. (SVU)
DryShips Inc. (DRYS)
Peregrine Pharmaceuticals, Inc. (PPHM)
Diana Containerships Inc. (DCIX)
DryShips Inc. (DRYS)
Marten Transport, Ltd. (MRTN)
Arena Pharmaceuticals, Inc. (ARNA)
Cobalt International Energy, Inc. (CIE)
CEL-SCI Corporation (CVM)
Amyris, Inc. (AMRS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AMRI Insider Buying

AMRI Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.